Artificial Intelligence3 years ago
New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis
SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a new clinical study supporting SciBase’s...